Bionomics Limited
NASDAQ:BNOX
0.2531 (USD) • At close December 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -0.805 | -0.081 | -5.237 | -4.94 | -10.416 | -5.228 | -11.034 | -5.183 | -6.011 | -9.484 | -6.512 | -0.01 | 0.261 | -4.701 | 1.072 |
| Depreciation & Amortization
| 0.166 | 662.22 | 0 | 0 | 0.771 | 0.387 | 0 | 0 | 0.766 | 0 | 1.275 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| -0.132 | 0 | 0 | 0 | -0.14 | 0 | 0 | 0 | -1.927 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.027 | 814.174 | 0 | 0 | 0.634 | 0.637 | 0 | 0 | 0 | 0 | 0.981 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -1.199 | 0 | 0 | 0 | 0.033 | 2.159 | 0 | 0 | -0.027 | 0 | 0.026 | 0 | 0 | 0 | 0 |
| Accounts Receivables
| 0.011 | 0 | 0 | 0 | 0.033 | 0.017 | 0 | 0 | -0.027 | 0 | 0.026 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| -0.918 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -0.292 | 0 | 0 | 0 | 2.135 | 2.143 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| -2.49 | -1,476.78 | 0.362 | 0.341 | 0.268 | -2.078 | 4.901 | 2.302 | -0.911 | 0.156 | 0.569 | -1.003 | -2.739 | 4.615 | -7.308 |
| Operating Cash Flow
| -4.433 | -0.467 | -4.876 | -4.598 | -8.215 | -4.123 | -6.133 | -2.881 | -6.156 | -9.329 | -4.668 | -1.013 | -2.477 | -0.086 | -6.236 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | -0 | -0.001 | 0 | -0.005 | -0.07 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.002 | 0.128 | -0.009 | 0.036 | -0.528 | 0.04 | 0.01 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.008 | 0 | -0.091 | 0 | 0.001 | -0.035 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.006 | 0.319 | -0 | 0 | -0.015 | 0.376 | 0 |
| Other Investing Activites
| 0 | -0.334 | 0.073 | 0.069 | 0.192 | 0.096 | 0.13 | 0.061 | 0.006 | 0.446 | -0.1 | 0.042 | 0 | 0.428 | 0 |
| Investing Cash Flow
| 0 | -0.334 | 0.073 | 0.069 | 0.192 | 0.096 | 0.13 | 0.061 | 0.005 | 0.446 | -0.1 | 0.041 | -0.542 | 0.423 | -0.06 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | -0.745 | 0.745 | 0 | -0.025 | -0.027 | -0.028 | -0.025 | 0 | -0.027 | -7.615 | -0.963 | -1.426 | -1.426 | -1.361 |
| Common Stock Issued
| 0 | 3.406 | 6.538 | 0 | -0.179 | 0 | 5.047 | 0 | -2.039 | 20.761 | 15.637 | 1.356 | 2.24 | 0 | -0.481 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.227 | 0.055 | -3.508 | 3.56 | -0.142 | -0.279 | -2.992 | -0.014 | -0.105 | -2.757 | 2.894 | 1.369 | 0.911 | -0.353 | -1.895 |
| Financing Cash Flow
| -0.227 | 2.716 | 3.775 | 3.56 | -0.265 | -0.306 | 4.054 | -0.039 | 1.671 | 17.856 | 21.831 | 1.881 | -0.045 | -3.558 | -3.257 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0.138 | 0 | -0.125 | -0.118 | -0.003 | -0.001 | -0.002 | 1.147 | -0.206 | -0.362 | 0.003 | -0.013 | 0 | -0.004 | 0 |
| Net Change In Cash
| -4.522 | -1.724 | -13.301 | -1.088 | -8.751 | -8.25 | -2.182 | -2.134 | -6.238 | 7.923 | 16.971 | 1.273 | -3.435 | -3.226 | -9.454 |
| Cash At End Of Period
| 8.165 | 8.42 | -1.153 | -1.088 | 12.148 | 22.449 | 20.899 | 31.431 | 23.081 | 29.319 | 21.396 | 4.425 | 3.152 | 6.587 | 9.814 |